睿创微纳(688002) - 2020 Q1 - 季度财报

Financial Performance - Operating income reached CNY 230,744,131.53, a 129.54% increase year-over-year [5] - Net profit attributable to shareholders surged by 265.87% to CNY 85,030,723.42 compared to the same period last year [5] - The company reported a net profit of ¥257,612,051.36 for Q1 2020, up from ¥198,539,825.88 in Q1 2019, which is an increase of approximately 30% [20] - The basic and diluted earnings per share for Q1 2020 were both ¥0.1911, compared to ¥0.0604 in Q1 2019, reflecting a growth of 216.4% [24] - Operating profit for Q1 2020 was ¥96,301,816.14, compared to ¥24,019,369.59 in Q1 2019, reflecting a growth of approximately 301% [21] Revenue and Sales - Revenue from civilian products accounted for 76.32% of total sales, growing by 125.47% year-over-year [5] - Sales related to temperature measurement products reached CNY 67,195,000, representing 29.12% of total revenue and a 137-fold increase compared to last year [5] - Total revenue for Q1 2020 reached ¥230,744,131.53, a significant increase from ¥100,525,120.88 in Q1 2019, representing a growth of approximately 129% [21] - The company's total revenue for Q1 2020 was approximately ¥99.26 million, a significant increase of 115.5% compared to ¥46.04 million in Q1 2019 [23] Cash Flow - The company generated a net cash flow from operating activities of CNY 20,601,285.99, a significant recovery from a negative cash flow of CNY -31,433,625.14 in the previous year [4] - The net cash flow from operating activities for Q1 2020 was ¥20,601,285.99, a significant improvement from the negative cash flow of ¥31,433,625.14 in Q1 2019 [14] - Operating cash inflow totaled CNY 267.85 million, a significant increase from CNY 98.30 million in the previous year [26] - Cash flow from financing activities resulted in a net inflow of CNY 49.88 million, compared to CNY 1.09 million last year [27] Assets and Liabilities - Total assets increased by 8.63% to CNY 2,763,881,207.17 compared to the end of the previous year [4] - Accounts receivable increased by 43.93% to RMB 165,238,340.65 from RMB 114,805,747.90 due to higher sales [11] - Total liabilities as of March 31, 2020, were ¥336,249,325.06, compared to ¥201,695,747.53 at the end of 2019, indicating a significant increase [18] - The total liabilities for Q1 2020 were ¥59,805,676.91, up from ¥53,473,627.35 in Q1 2019, indicating an increase of about 12% [20] Research and Development - The company’s R&D expenditure accounted for 12.59% of operating income, a decrease of 7.19 percentage points from the previous year [5] - Research and development expenses increased by 46.07% to RMB 29,039,927.82 from RMB 19,880,893.91, reflecting higher investment in R&D [13] - Research and development expenses for Q1 2020 were ¥7.67 million, down from ¥11.03 million in Q1 2019, showing a decrease of 30.5% [23] Inventory and Production - Inventory rose by 30.62% to RMB 384,533,269.74 from RMB 294,398,028.38, driven by increased production and stock [11] - The company's inventory increased to ¥384,533,269.74 in Q1 2020, up from ¥294,398,028.38 in Q1 2019, reflecting a growth of approximately 30.6% [16] Other Financial Metrics - The weighted average return on net assets increased to 3.57%, up by 1.29 percentage points from the previous year [4] - The company reported a tax expense of ¥7.26 million for Q1 2020, compared to ¥2.30 million in Q1 2019, which is an increase of 215.2% [23] - The company reported a financial expense of approximately -¥5.28 million in Q1 2020, compared to -¥0.30 million in Q1 2019, indicating a significant change in financial costs [23]